Evidence map›Paper›PMID 18631972›Full record

ReviewAlzheimer's & dementia : the journal of the Alzheimer's Association2008

Perspective on race and ethnicity in Alzheimer's disease research.

Myron F Weiner

Abstract readEditorialReview
In one paragraph

Review in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.5field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Intersectionality in Alzheimer's Disease: The Role of Female Sex and Black American Race in the Development and Prevalence of Alzheimer's Disease.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2023
    Review
  7. Article
  8. Article
  9. Culture, Ethnicity, and Level of Education in Alzheimer's Disease.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2022
    Review
  10. Personalizing the Care and Treatment of Alzheimer's Disease: An Overview.Pharmacogenomics and personalized medicine · 2021
    Review
  11. Article
  12. Review
  13. Article
  14. Pharmaceutical and medicinal significance of sulfur (SEuropean journal of medicinal chemistry · 2019
    Review
  15. Dementia in the USA: state variation in prevalence.Journal of public health (Oxford, England) · 2015
    Article
  16. Article
  17. Leptin and cognition.Dementia and geriatric cognitive disorders · 2012
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Myron F WeinerDepartment of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA. myron.weiner@utsouthwestern.edu
The University of Texas Southwestern Medical Center · US

Funding

ROLE OF GLUTAMATE IN ALZHEIMER'S DISEASEP30AG012300 · NIA · UT SOUTHWESTERN MEDICAL CENTER · PI ROSENBERG, ROGER NEWMAN · 1994 to 2016
$26.6M
NIA NIH HHS AG 12300NIA NIH HHS P30 AG012300
6 · The paper itself

Abstract

There are adequate scientific, public health, and ethical justifications for studying Alzheimer's disease (AD) in persons of varying race and ethnicity, but to be meaningful variables, race and ethnicity must be examined in context. The complex interactions between race, ethnicity, lifestyle, and environmental factors, such as climate and diet, require that future studies of AD in specific racial or ethnic groups attend to measures of racial/ethnic homogeneity and the assessment of the environment and the elements that comprise the ethnicity of groups under study. Instead of arbitrarily selecting specific racial or ethnic groups in the hope of finding important differences, it may be in the long run less costly and more efficient to recruit families with highly positive (or negative) family histories, to search within these groups for possible racial or ethnic differences, and to investigate the possible racial or ethnic reasons for those differences.

Indexed as

EthnicityRacial GroupsAlzheimer DiseaseHumans

Identifiers

PMID18631972
PMCPMC2570194
OpenAlexW2165455141

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.